Management of diabetes and associated cardiovascular risk factors in seven countries: A comparison of data from national health examination surveys

Bulletin of the World Health Organization

Volumn 89, Issue 3, 2011, Pages 172-183

  Gakidou, Emmanuela ^a   Mallinger, Leslie ^a   Abbott Klafter, Jesse ^b   Guerrero, Ramiro ^c   Villalpando, Salvador ^d   Ridaura, Ruy Lopez ^d   Aekplakorn, Wichai ^e   Naghavi, Mohsen ^a   Lim, Stephen ^a   Lozano, Rafael ^a   Murray, Christopher J L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD UNIVERSITY   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR DISEASE; DIABETES; DISEASE CONTROL; DISEASE TREATMENT; HEALTH RISK; HEALTH SURVEY; PUBLIC HEALTH; RISK FACTOR;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; COLOMBIA; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; INCOME; IRAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PATIENT CARE; PATIENT EDUCATION; PREDICTION; PREVALENCE; SEX DIFFERENCE; SOCIAL STATUS; THAILAND; UNITED KINGDOM; UNITED STATES; URBAN RURAL DIFFERENCE;

ADULT; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; FEMALE; HEALTH SURVEYS; HEALTHCARE DISPARITIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

COLOMBIA; ENGLAND; IRAN; MEXICO [NORTH AMERICA]; SCOTLAND; THAILAND; UNITED KINGDOM; UNITED STATES;

EID: 79952338226     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.10.080820     Document Type: Article

References (38)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14. doi:10.1016/j.diabres.2009.10.007 PMID:19896746
2. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010;87:15-19. doi:10.1016/j.diabres.2009.10.006 PMID:19914728
3. Aekplakorn W, Abbott-Klafter J, Premgamone A, Dhanamun B, Chaikittiporn C, Chongsuvivatwong V, et.al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 2007;30:2007-2012. doi:10.2337/dc06-2319 PMID:17468342
4. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et.al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268. doi:10.2337/dc06-0062 PMID:16732006
5. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X etal.; InterASIA Collaborative Group. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46:1190-1198. doi:10.1007/s00125-003-1167-8 PMID:12879248
6. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, et.al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 2006;29:226-231. doi:10.2337/diacare.29.02.06.dc05-0481 PMID:16443864
7. Mainous AG 3rd, Diaz VA, Saxena S, Baker R, Everett CJ, Koopman RJ, et.al. Diabetes management in the USA and England: comparative analysis of national surveys. J R Soc Med 2006;99:463-469. doi:10.1258/jrsm.99.9.463 PMID:16946390
8. Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005;36:188-196. doi:10.1016/j.arcmed.2005.01.006 PMID:15925009
9. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et.al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334-299. doi:10.1136/bmj.39063.689375.55 PMID:17237299
10. Bertram MY, Lim SS, Barendregt JJ, Vos T. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 2010;53:875-881. doi:10.1007/s00125-010-1661-8 PMID:20135088
11. Hamnvik OP, McMahon GT. Glycemic targets for patients with type 2 diabetes mellitus. Mt Sinai J Med 2009;76:227-233. doi:10.1002/msj.20117 PMID:19421966
12. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et.al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009;373:1765-1772. doi:10.1016/S0140-6736(09)60697-8 PMID:19465231
13. Zarich SW. Antidiabetic agents and cardiovascular risk in type 2 diabetes. Nat Rev Endocrinol 2009;5:500-506. doi:10.1038/nrendo.2009.150 PMID:19636325
14. Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-1217. doi:10.1056/NEJM199505043321807 PMID:7700316
15. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002;347:1342-1349. doi:10.1056/NEJMcp021106 PMID:12397193
16. Mourad JJ, Le Jeune S. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. J Hypertens Suppl 2008;26:S7-S13. PMID:19363847
17. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A, et.al. UKADS Study Group. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet 2008;371:1769-1776. doi:10.1016/S0140-6736(08)60764-3 PMID:18502301
18. Foley RN, Collins AJ. The growing economic burden of diabetic kidney disease. Curr Diab Rep 2009;9:460-465. doi:10.1007/s11892-009-0075-9 PMID:19954692
19. Sosa-Rubí SG, Galárraga O, López-Ridaura R. Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull World Health Organ 2009;87:512-519. doi:10.2471/BLT.08.053256 PMID:19649365
20. Rodríguez J, Ruiz F, Peñaloza E, Eslava J, Gómez LC, Sánchez H, et al. Encuesta Nacional de Salud 2007: resultados nacionales. Bogota: Ministry of Health and Social Protection; 2009.
21. Health survey for England 2003: summary of key findings. London: National Centre for Social Research, Department of Epidemiology and Public Health; 2004. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4098712 [accessed 6 November 2010].
22. Asgari F, Aghajani H, Haghazali M, Heidarian H. Non-communicable diseases risk factors surveillance in Islamic Republic of Iran. Iran J Public Health 2009;38(Suppl 1):119-122.
23. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, et.al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex 2010;52(Suppl 1):S19-S26. PMID:20585724
24. The Scottish Health Survey 2003: summary of key findings. Edinburgh: The Scottish Executive Health Department; 2005. Available from: http://www.scotland.gov.uk/Resource/Doc/924/0021055.pdf [accessed 6 November 2010].
25. National Health and Nutrition Examination Survey 2003-2006. Hyattsville: National Center for Health Statistics. Available from: http://www.cdc.gov/nchs/nhanes.htm [accessed 6 November 2010].
26. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation; 2005.
27. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: National Collaborating Centre for Chronic Conditions (Great Britain), Royal College of Physicians; 2008.
28. Guide 17: guide for care of diabetes mellitus type 2. In: Guidelines for health promotion and disease prevention in public health, volume 2. Bogota: Ministry of Social Protection; 2007.
29. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: National Institute for Clinical Excellence; 2008.
30. Delavari A, Mahdavihazaveh A, Norozinejad A, Yahramadi S. National health programme for control and prevention of diabetes for Behvarzes. Tehran: Center for Disease Control, Ministry of Health and Medical Education; 2004.
31. Mexican official standard for the prevention, treatment, and control of diabetes (NOM-015-SSA2-1994). Mexico City: Secretaría de Salud; 1994. Spanish.
32. Clinical practice guideline for management of diabetes 2008. Bangkok: Diabetes Association of Thailand, Endocrine Society of Thailand & National Health Security Office; 2008.
33. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32:S13-S61. PMID:19118285
34. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et.al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-489. doi:10.1016/S0140-6736(09)61969-3 PMID:20110121
35. Roland M. Linking physicians' pay to the quality of care - a major experiment in the United Kingdom. N Engl J Med 2004;351:1448-1454. doi:10.1056/NEJMhpr041294 PMID:15459308
36. Khonputsa P, Veerman JL, Vos ET, Aekplakorn W, Bertram M, Abbott-Klafter J, et al. Joint prevalence and control of hypercholesterolemia and hypertension in Thailand: third National Health Examination Survey. Asia Pc J Public Health Epub 2010 Aug 3.
37. Filion KB, Joseph L, Boivin JF, Suissa S, Brophy JM. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf 2009;18:973-976. doi:10.1002/pds.1802 PMID:19621344
38. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453. doi:10.1210/jc.2007-2174 PMID:18460560